Washington, DC
Our headquarters in the US capital grants us a unique advantage in comprehending and navigating the intricacies of policy and regulatory matters, allowing us to deliver unparalleled insights on how these issues impact your investments and business decisions.
1401 New York Ave NW, Ste 600
Washington, DC 20005
202-449-9862
Our Latest Insights
US-India Relations Hit a Roadblock (Again)
August 6, 2025 By Alexander Slater, Managing Director American investors and companies that are looking at India as their next big opportunity or an alternative supply chain node to China, as well as Indian companies seeking to enter or expand their footprint in the...
The 340B Dilemma: The Power of Vague Law
July 21, 2025 By Angela Lamari, Capstone Healthcare analyst At only eight and a half pages of statute, the federal 340B drug pricing program is a clear example of how industry speaks when the law is silent. The program itself is fairly simple—in 1992, the government...
What Comes Next After the US Strikes on Iran?Â
July 8, 2025 By Daniel Silverberg and Elena McGovern, Co-Heads of Capstone’s National Security Practice With direct military confrontation among the US, Israel and Iran de-escalated—for now—Capstone is tracking three key questions on behalf of clients: 1. Did...
